ARIAD Announces FDA Clearance to Begin Clinical Development of AP32788
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 23.09 -1.19 (4.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.28 | 52 Week High | $14.34 | |||
| Open | $23.24 | 52 Week Low | $4.37 | |||
| Day High | $23.30 | P/E | N/A | |||
| Day Low | $23.09 | EPS | $-1.45 | |||
| Volume | 1,198 | |||||
